Healthcare industry reports 86 deals worth $25.5 billion in Oct 2020
Three major deals contributes 72 per cent of total deal value
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
M&A
Aurobindo Pharma acquires 100 per cent share of Eugia Pharma Specialities
The cost of acquisition is Rs 274.22 crores for a total of 15,02,49,382 equity shares
HitGen to acquire Vernalis for $25 mn in cash
The closing of this transaction is subject to customary conditions and approvals, expected to complete before the end of 2020
Sequent Scientific to buy balance stake in veterinary pharma firm, Fendigo BV
The said transaction is expected to be completed on or before October 31, 2020
Pharma manufacturing across Southern India has strong M&A potential: GlobalData
Karnataka has one of the fastest-growing pharma sectors in India: approximately 40 per cent of the state’s pharma production is…
DWK Life Sciences acquires Müller + Müller
Müller + Müller will be managed by CEO Florian Müller-Stauch
Bristol Myers Squibb to acquire Forbius
Forbius’s lead TGF-beta asset, AVID200, is an isoform-selective TGF-beta inhibitor, currently in Phase 1 for oncology and fibrosis
Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases
Advent International to acquire controlling stake in RA Chem Pharma from Micro Labs
The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million